During the past decade, Centro Integral de Oncología conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro Integral de Oncología" are "Breast Neoplasms" (2 trials). Many other conditions were trialed in "Centro Integral de Oncología" in a lesser frequency.

Most popular intervention types in "Centro Integral de Oncología" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (1 trials), "Herceptin" (1 trials), "Nab-paclitaxel" (1 trials), "Paclitaxel" (1 trials) and "Pertuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Integral de Oncología" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centro Integral de Oncología". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centro Integral de Oncología, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Integral de Oncología, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".